share_log

Wells Fargo Maintains Overweight on Medtronic, Lowers Price Target to $98

Benzinga ·  Nov 20 09:23  · Ratings

Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and lowers the price target from $106 to $98.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment